A trend toward increased first trimester free β-hCG and PAPP-A in monochorionic twins complicated by Twin-to-Twin Transfusion syndrome

Prenatal Diagnosis

Volumn 30, Issue 9, 2010, Pages 909-910

  Linskens, I H ^a   Engels, M ^a   Oepkes, D ^b   Heijboer, A C ^a   Blankenstein, M A ^a   Van Vugt, J M G ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Free hCG; Monochorionic twins; PAPP A; TTTS

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ARTICLE; FIRST TRIMESTER PREGNANCY; HUMAN; MATERNAL SERUM; MONOCHORIONIC TWIN PREGNANCY; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY OUTCOME; PRENATAL SCREENING; PRIORITY JOURNAL; TREND STUDY; TWIN PREGNANCY; TWIN TWIN TRANSFUSION SYNDROME;

ADULT; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; FEMALE; FETOFETAL TRANSFUSION; HUMANS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; YOUNG ADULT;

EID: 77956158740     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2591     Document Type: Article

References (11)

1. Berghella V, Kaufmann M. 2001. Natural history of twin-twin transfusion syndrome. J Reprod Med 46(5): 480-484.
2. Dugoff L, Hobbins JC, Malone FD, et al. 2004. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER trial). Am J Obstet Gynecol 191(4): 1446-1451.
3. Fox CE, Pretlove SJ, Chan BC, Mahony RT, Holder R, Kilby MD. 2009. Maternal serum markers of placental damage in uncomplicated dichorionic and monochorionic pregnancies in comparison with monochorionic pregnancies complicated by severe twin-to-twin transfusion syndrome and the response to fetoscopic laser ablation. Eur J Obstet Gynecol Reprod Biol 144(2): 124-129.
4. Kagan KO, Gazzoni A, Sepulveda-Gonzalez G, Sotiriadis A, Nicolaides KH. 2007. Discordance in nuchal translucency thickness in the prediction of severe twin-to-twin transfusion syndrome. Ultrasound Obstet Gynecol 29(5): 527-532.
5. Kusanovic JP, Romero R, Espinoza J, et al. 2008. Twin-to-twin transfusion syndrome: an antiangiogenic state?. Am J Obstet Gynecol 198(4): 382-388.
6. Lewi L, Jani J, Blickstein I, et al. 2008. The outcome of monochorionic diamniotic twin gestations in the era of invasive fetal therapy: a prospective cohort study. Am J Obstet Gynecol 199(5): 514-518.
7. Linskens IH, de Mooij YM, Twisk JW, Kist WJ, Oepkes D, van Vugt JM. 2009. Discordance in nuchal translucency measurements in monochorionic diamniotic twins as predictor of twin-to-twin transfusion syndrome. Twin Res Hum Genet 12(6): 605-610.
8. Muller F, Dreux S, Dupoizat H, et al. 2003. Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity. Prenat Diagn 23(4): 331-335. (Pubitemid 36457270)
9. Quintero RA, Morales WJ, Allen MH, Bornick PW, Johnson PK, Kruger M. 1999. Staging of twin-twin transfusion syndrome. J Perinatol 19(8 Pt 1): 550-555.
10. Sepulveda W, Sebire NJ, Hughes K, Odibo A, Nicolaides KH. 1996. The lambda sign at 10-14 weeks of gestation as a predictor of chorionicity in twin pregnancies. Ultrasound Obstet Gynecol 7(6): 421-423. (Pubitemid 126720282)
11. Sermondade N, Dreux S, Oury JF, Muller F. 2009. Second-trimester maternal serum screening for Down syndrome in twin-to-twin transfusion syndrome. Prenat Diagn 29(8): 814-815.